Here are comments on the recent paper on the determination of inositol hexaphosphate (IP 6 ) in human plasma and on its efficacy.
or toxicity. A common sense question: Is the menace of cancer, kidney stone and other diseases any less than the hypothetical (and unsubstantiated) putative deficiency of cations that can be easily corrected?
There are other flaws in the paper that though may appear minor do, nevertheless, reflect poorly on the report and the authors' credibility in culling scientific data, e.g. Eiseman et al. [16] studied the pharmacokinetics in mice and not rats as described; the metabolism in the two species are different.
Finally, making conclusions and recommendations that are not supported by data and are at variance with logic, may erode public trust in science. Because the field of inositol phosphates and the use of IP 6 in human diet have strongly polarized and sharply divided scientists, an open, healthy discussion, and some critical evaluations are needed.
